TissueScan, Prostate Cancer cDNA Array II

CAT#: HPRT102

48 samples covering 8-normal, 22-Stage IIA, 11-III, 2-IV, 5-N/R. Available in 2, 5, 10 identical plates.

USD 850.00

Availability*
In Stock
Size
    • 2 Panels

Product images

Specifications

Product Data
Array Category Cancer Specific
Clinical Info
Diagnosis Prostate Cancer
Tissue Prostate
Array Name Prostate Cancer cDNA Array II
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.

Citations

The use of this Tissues has been cited in the following citations:
Inherited Variants in Wnt Pathway Genes Influence Outcomes of Prostate Cancer Patients Receiving Androgen Deprivation Therapy ,Geng, JH;Lin, VC;Yu, CC;Huang, CY;Yin, HL;Chang, TY;Lu, TL;Huang, SP;Bao, BY;, Int J Mol Sci 2016,PubMed ID 27898031 [Prostate Cancer]
Recurrent cis-SAGe chimeric RNA, D2HGDH-GAL3ST2, in prostate cancer ,Qin, F;Song, Z;Chang, M;Song, Y;Frierson, H;Li, H;, Cancer Lett. Jun 2016,PubMed ID 27322736
12-HETER1/GPR31, a high-affinity 12(S)-hydroxyeicosatetraenoic acid receptor, is significantly up-regulated in prostate cancer and plays a critical role in prostate cancer progression ,Honn, KV;Guo, Y;Cai, Y;Lee, MJ;Dyson, G;Zhang, W;Tucker, SC;, FASEB J. Mar 2016,PubMed ID 26965684
Crosstalk between RON and androgen receptor signaling in the development of castration resistant prostate cancer ,Batth, I;Yun, H;Hussain, S;Meng, P;Osumulski, P;Huang, TH;Bedolla, R;Profit, A;Reddick, R;Kumar, A;, Oncotarget Feb 2016,PubMed ID 26872377
Identifying Mediators of Androgen-independent Prostate Cancer Using Mass Spectrometry-based Proteomics ,Saraon, P;, Thesis Dec 2014 [HPRT102]
TRIB1 supports prostate tumorigenesis and tumor-propagating cell survival by regulation of endoplasmic reticulum chaperone expression ,Mashima, T;Soma-Nagae, T;Migita, T;Kinoshita, R;Iwamoto, A;Yuasa, T;Yonese, J;Ishikawa, Y;Seimiya, H;, Cancer Res. Jun 2014,PubMed ID 24962028 [TF81001]
The role of sLZIP in cyclin D3-mediated negative regulation of androgen receptor transactivation and its involvement in prostate cancer ,Kim, Y;Kim, J;Jang, SW;Ko, J;, Oncogene, Jan 2014.,PubMed ID 24441043 [Prostate Cancer qPCR Array Panel II]
Quantitative Proteomics Reveals That Enzymes of the Ketogenic Pathway Are Associated with Prostate Cancer Progression ,Punit Saraon, Daniela Cretu, Natasha Musrap, George S. Karagiannis, Ihor Batruch, Andrei P. Drabovich, Theodorus van der Kwast, Atsushi Mizokami, Colm Morrissey, Keith Jarvi, and Eleftherios P. Diamandis, Mol. Cell. Proteomics, Jun 2013; 12: 1589 - 1601.,PubMed ID 23443136 [Prostate Panel II]
The Stress Response Mediator ATF3 Represses Androgen Signaling by Binding the Androgen Receptor ,Hongbo Wang, Ming Jiang, Hongmei Cui, Mengqian Chen, Ralph Buttyan, Simon W. Hayward, Tsonwin Hai, Zhengxin Wang, and Chunhong Yan, Mol. Cell. Biol., Aug 2012; 32: 3190 - 3202. [Prostate Cancer Panel II]

Related Products (2)